EUVIMEDEUVIMED entdecken
Crossref

Pharmacokinetic Study of Eight Bioactive Components of Buyang Huanwu Decoction in LPS Induced Chronic Inflammatory and Control Rats Using UPLC‐MS/MS

Li Jiang iD, Yanling Xiong, Weiwei Wang, Yuting Zheng, Liping Huang, Yuhui Liu, Guoliang Xu iD

Biomedical Chromatography · 2025

DOI: 10.1002/bmc.70117 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biomedical Chromatography, 2025. Verfasst von Li Jiang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Research Center for Differentiation and Development of TCM Basic Theory, Jiangxi University of Chinese Medicine, Nanchang, China. Hauptthemen laut MEDLINE: Drugs, Chinese Herbal, Tandem Mass Spectrometry, Inflammation. Die Arbeit nennt 50 Literaturangaben. Gefördert von: Jiangxi Provincial Health Commission Science and Technology Plan Project, Jiangxi Traditional Chinese Medicine Young and Middle-aged Backbone Talents Program, Jiangxi University of Chinese Medicine Science and Technology Innovation Team Development Plan.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Inflammation plays a pivotal role in the pathogenesis of numerous chronic inflammatory diseases, including cardiovascular diseases. Buyang Huanwu decoction (BYHWD) is widely employed to treat chronic inflammation and related disorders. However, the pharmacokinetics of BYHWD's active compounds under inflammatory conditions remain unclear. This study aims to investigate the comparative pharmacokinetics of eight bioactive components in control and LPS‐induced chronic inflammatory rats following oral administration of BYHWD. A chronic inflammatory rat model was established by administering low‐dose lipopolysaccharide (LPS, 200 μg / kg) via tail vein injection. An ultra‐performance liquid chromatography–tandem mass spectrometry (UPLC‐MS/MS) method was developed for simultaneous quantification of eight major bioactive components of BYHWD in rat plasma. Subsequently, the pharmacokinetic profiles of these analytes were characterized in both control and inflammatory rats. Excellent linearity ( R 2 > 0.9958) was observed for all analytes in rat plasma samples. Absolute recoveries ranged from 50.84% to 111.86%, and matrix effects varied between 85.04% and 110.14%. The method met the criteria for intra‐ and inter‐day precision, accuracy, and stability. In conclusion, the established UPLC‐MS/MS method reliably investigated the pharmacokinetic characteristics of BYHWD's bioactive components and indicate that chronic inflammation may reduce the absorption of these compounds, providing valuable insights into BYHWD's clinical applications.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Drugs, Chinese HerbalTandem Mass SpectrometryInflammationAnimalsRatsChromatography, High Pressure LiquidMaleLipopolysaccharidesRats, Sprague-DawleyReproducibility of ResultsLinear ModelsLimit of DetectionLiquid Chromatography-Mass Spectrometry

Stichwörter der Autor:innen

Buyang Huanwu decoctionUPLC‐MS/MSchronic inflammatory ratspharmacokinetic

Substanzen

Drugs, Chinese HerbalLipopolysaccharidesbuyang huanwu

Autor:innen und Institutionen

  • Research Center for Differentiation and Development of TCM Basic Theory, Jiangxi University of Chinese Medicine, Nanchang, China.
  • Jiangxi Provincial Key Laboratory of TCM Etiopathogenesis, Jiangxi University of Chinese Medicine, Nanchang, China.
  • Key Laboratory of Pharmacology of Traditional Chinese Medicine in Jiangxi, Nanchang, China.
  • Department of Pharmacy, The First Hospital of Nanchang, The Third Affiliated Hospital of Nanchang University, Jiangxi Medical College, Nanchang University, Nanchang, China.
  • Department of Pharmacy, Affiliated Hospital of Jinggangshan University, Ji'an, China.

ORCID-Profile: Li Jiang, Guoliang Xu

Förderung

  • Jiangxi Provincial Health Commission Science and Technology Plan Project
  • Jiangxi Traditional Chinese Medicine Young and Middle-aged Backbone Talents Program
  • Jiangxi University of Chinese Medicine Science and Technology Innovation Team Development Plan
  • National Natural Science Foundation of China
  • Key Project of Jiangxi Provincial Natural Science Foundation
  • Science and Technology Program of Jiangxi Provincial Administration of Traditional Chinese Medicine

Zitieren

APA

Jiang, L., Xiong, Y., Wang, W., Zheng, Y., Huang, L., Liu, Y., & Xu, G. (2025). Pharmacokinetic Study of Eight Bioactive Components of Buyang Huanwu Decoction in LPS Induced Chronic Inflammatory and Control Rats Using UPLC‐MS/MS. Biomedical Chromatography. https://doi.org/10.1002/bmc.70117

Vancouver

Jiang L, Xiong Y, Wang W, Zheng Y, Huang L, Liu Y, et al. Pharmacokinetic Study of Eight Bioactive Components of Buyang Huanwu Decoction in LPS Induced Chronic Inflammatory and Control Rats Using UPLC‐MS/MS. Biomedical Chromatography. 2025. doi:10.1002/bmc.70117

BibTeX
@article{Jiang2025,
  author = {Jiang, Li and Xiong, Yanling and Wang, Weiwei and Zheng, Yuting and Huang, Liping and Liu, Yuhui and Xu, Guoliang},
  title = {Pharmacokinetic Study of Eight Bioactive Components of Buyang Huanwu Decoction in LPS Induced Chronic Inflammatory and Control Rats Using UPLC‐MS/MS},
  journal = {Biomedical Chromatography},
  year = {2025},
  doi = {10.1002/bmc.70117}
}
Kostenlos starten →